Smith & Nephew plc reportedly spurns a $10.9 billion buyout offer from Johnson & Johnson; Biomet, Stryker and Zimmer could also be players in the action.
Smith & Nephew plc (NYSE:SNN) shares jumped nearly 12 percent on news that it spurned a $10.9 billion buyout bid from Johnson & Johnson (NYSE:JNJ), according to Sky News (via RTT News).
News of the roughly $11.65-per-share offer sent SNN shares up to $56.56 in pre-market activity today. New Brunswick, N.J.-based Johnson & Johnson made the bid before Christmas, according to Sky News. Smith & Nephew’s board rejected the bid as substantially under-valued, but JNJ might raise the ante, according to the British news channel.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Warsaw, Ind.-based Biomet Inc. is also in the running for the British orthopedics giant, according to the report, waiting on JNJ to raise the stakes before making its move. Other likely players include Biomet’s fellow Lake City denizen Zimmer Holdings Inc. (NYSE:ZMH) and Stryker Corp. (NYSE:SYK) of Kalamazoo, Mich., according to Sky.
JNJ shares were down $0.10 at $62.50 a share in U.S. pre-trade.
Smith & Nephew (S&N) declined to comment, but the company may now come under pressure to issue a statement, following the sharp rise in its shares. Under British takeover rules, companies are obliged to inform the market of an approach if the news leaks and influences its shares.
Dave Price contributed to this report.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
